RE:RE:RE:RE:RE:Any guessesI would say it's a little too "neat" and conveniant for you to pretend like "pace" doesn't matter while you hope and preach about some "magical", early end to the trial. (year after year)
As an investor, I would much rather see management achieve real numbers and actual results. Straightforward stuff. But yes, that would require leaders who actually did their job and delivered on the "worst case" enrollment numbers they set for themselves. (I'll post a link to the AGM for clarity)
But I don't think "pace" is the only reason shareholders think as you say- "leaders suck" I think that's also because of:
-The Dialco mess and the complete disregard for real disclosure around it.
-Lack of transparency in general. (see Baxter deal, see Confirmed Partner #2", June Infomed contract issues...)
-Lack of credibility after 2 yrs of talking about starting DIMI trial and never getting close, or Seto's -reaching 90 patients by end of 2021 statements.
-Lack of accountability taken when they don't deliver.
-The pocket stuffing of millions of warrants- despite the lack of results.
-Financings that chop off 10%ish per year through dilution..
But you know all of these sucky reasons as you complain about them yourself from time to time.
https://spectraldx.com/wp-content/uploads/2022/09/spectral-investor-update-september-2022.pdf